Skip to main content
GutCited

Butyrate (Sodium/Calcium Butyrate) cho Crohn's Disease

C

Oral butyrate (4 g/day for 8 weeks) improved CDAI scores in open-label study. Controlled evidence still limited.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'gutcited.com'; const params = 'ingredient\u003Dbutyrate\u0026condition\u003Dibd\u002Dcrohns\u002Ddisease'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

C

Kết luận

Oral butyrate (4 g/day for 8 weeks) improved CDAI scores in open-label study. Controlled evidence still limited.

Key Study Findings

Randomized Controlled Trial n=140 Double-blind
Impact of oral butyrate on clinical and biochemical parameters in IBD: A randomized placebo-controlled study …
Dose: None so với: placebo plus conventional therapy Outcome: clinical disease activity and fecal calprotectin Hiệu quả: None p=0.013

Đối tượng nghiên cứu: IBD patients (60 Crohn's disease, 80 ulcerative colitis)

In Vitro
Sodium butyrate alleviates DSS-induced inflammatory bowel disease by inhibiting ferroptosis and modulating ERK/STAT3 signaling and …
Dose: Low-dose and high-dose NaB so với: DSS-induced IBD mice; 5-ASA control Outcome: IBD symptom alleviation and ferroptosis inhibition Hiệu quả: None None

Đối tượng nghiên cứu: DSS-induced IBD murine model

In Vitro
Effects of Lactobacillus paracei JY062 Postbiotic on Intestinal Barrier, Immunity, and Gut Microbiota.
Dose: 5 mg/mL so với: LPS-treated cell models Outcome: Intestinal barrier function and gut microbiota Hiệu quả: None None

Đối tượng nghiên cứu: Caco-2 cells, RAW264.7 macrophages, fecal fermentation

Other
Association of Inflammatory Factors and Calcium Metabolism With Arthritis in Patients With Inflammatory Bowel Disease: …
Dose: None so với: None Outcome: Causal associations IBD → arthritis subtypes (MR) Hiệu quả: OR=1.21 (IBD→AS); OR=1.18 (IBD→PsA) <0.001 (AS); 0.007 (PsA)

Đối tượng nghiên cứu: Mendelian randomization study of IBD and arthritis

Observational Study n=212
Microbiome multi-omics analysis reveals novel biomarkers and mechanisms linked with CD etiopathology.
Dose: None so với: Healthy controls Outcome: CD-specific microbiome signatures (AUC 0.94) Hiệu quả: AUC 0.94 in external validation None

Đối tượng nghiên cứu: Crohn's disease and ulcerative colitis patients

In Vitro
Effects of senotherapeutics on gut microbiome dysbiosis and intestinal inflammation in Crohn's disease: A pilot …
Dose: None so với: Untreated Crohn's disease microbiota Outcome: Gut microbiome modulation and inflammation Hiệu quả: None None

Đối tượng nghiên cứu: Crohn's disease fecal microbiota in SHIME model

Key Statistics

2

Nghiên cứu

200

Người tham gia

Positive

C

Xếp hạng

Referenced Papers

Langenbeck's archives of … 2025 3 trích dẫn
Current opinion in … 2019 5 trích dẫn
Current pharmaceutical design 2018 108 trích dẫn
Gastroenterology 2017 335 trích dẫn
Innate immunity 2017 13 trích dẫn
Alimentary pharmacology & … 2005 227 trích dẫn
Alimentary pharmacology & … 2003 179 trích dẫn
Current opinion in … 2001 45 trích dẫn
Current opinion in … 2001 38 trích dẫn
Current opinion in … 2000 21 trích dẫn
Diseases of the … 1998 26 trích dẫn
Digestive diseases (Basel, … 1993 29 trích dẫn

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Liều lượng thường dùng

general:
150-600 mg/day sodium or calcium butyrate
ibdsupport:
300-600 mg three times daily (900-1,800 mg/day)
butyrateenema:
100 mM butyrate enema for distal UC (clinical setting only)

Giới hạn trên: No established upper limit for oral supplements; most studies use 600-4,000 mg/day

Liều lượng đã nghiên cứu

Liều lượng Thời gian Hiệu quả N
None -- Positive 140
Low-dose and high-dose NaB -- Positive --
5 mg/mL -- Positive --
None -- Positive --
None -- Positive 212
None -- Positive --
None -- Negative --
None -- Mixed --

Thời điểm dùng tốt nhất: With meals; enteric-coated formulations recommended to reach the colon

Safety & Side Effects

Tác dụng phụ đã được báo cáo

  • Unpleasant taste/odor (butyric acid has a strong rancid butter smell)
  • Mild GI discomfort (nausea, bloating)
  • Belching with butyric acid odor
  • Enteric-coated formulations reduce taste issues

Tương tác đã biết

  • 5-ASA medications (mesalamine) — additive anti-inflammatory effect (potentially beneficial in IBD)
  • No significant adverse drug interactions known

Mức hấp thụ tối đa cho phép: No established upper limit for oral supplements; most studies use 600-4,000 mg/day

Luôn tham khảo ý kiến bác sĩ trước khi bắt đầu sử dụng bất kỳ thực phẩm bổ sung nào.Luôn tham khảo ý kiến chuyên gia y tế trước khi sử dụng bất kỳ thực phẩm chức năng nào.

Frequently Asked Questions

Does Butyrate (Sodium/Calcium Butyrate) help with Crohn's Disease?
Based on 2 studies with 200 participants, there is limited but promising evidence that Butyrate (Sodium/Calcium Butyrate) may support Crohn's Disease management. Our evidence grade is C (Some Evidence).
How much Butyrate (Sodium/Calcium Butyrate) should I take for Crohn's Disease?
Studies have used various dosages. A commonly studied range is 150-600 mg/day sodium or calcium butyrate. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Butyrate (Sodium/Calcium Butyrate)?
Reported side effects may include Unpleasant taste/odor (butyric acid has a strong rancid butter smell), Mild GI discomfort (nausea, bloating), Belching with butyric acid odor, Enteric-coated formulations reduce taste issues. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Butyrate (Sodium/Calcium Butyrate) and Crohn's Disease?
We rate the evidence as Grade C (Some Evidence). This rating is based on 2 peer-reviewed studies with 200 total participants. The overall direction of effect is positive.

Related Evidence

Các thành phần khác cho Crohn's Disease

Butyrate (Sodium/Calcium Butyrate) cho các tình trạng khác

Tuyên bố miễn trừ FDA: Các tuyên bố này chưa được Cục Quản lý Thực phẩm và Dược phẩm (FDA) đánh giá. Các sản phẩm và thông tin trên trang web này không nhằm mục đích chẩn đoán, điều trị, chữa bệnh hoặc phòng ngừa bất kỳ bệnh nào. Xếp hạng bằng chứng được trình bày dựa trên phân tích của chúng tôi về nghiên cứu đã bình duyệt được công bố và không cấu thành tư vấn y khoa. Luôn tham khảo ý kiến chuyên gia y tế trước khi bắt đầu bất kỳ chế độ thực phẩm chức năng nào.